Infection in heart transplantation;Infecciones en el trasplante cardíaco

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 25, Issue 9, 2007, Pages 587-598

  Gurguí, Mercè ^a,c   Muñoz, Patricia ^b  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^c HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

Bacterial infections; Cytomegalovirus infection; Heart trasplantation; Toxoplasmosis

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; AMOXICILLIN PLUS CLAVULANIC ACID; AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIVIRUS AGENT; AZITHROMYCIN; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; COTRIMOXAZOLE; DOXYCYCLINE; GANCICLOVIR; IMIPENEM; ITRACONAZOLE; LEVOFLOXACIN; METRONIDAZOLE; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULTAMICILLIN; UNINDEXED DRUG; VORICONAZOLE;

ALLOGRAFT; ASPERGILLOSIS; BACTERIAL INFECTION; CANDIDIASIS; CATHETER INFECTION; CHAGAS DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COCCIDIOIDOMYCOSIS; CRYPTOCOCCOSIS; CYTOMEGALOVIRUS; EPSTEIN BARR VIRUS; GRAFT SURVIVAL; HEART DISEASE; HEART TRANSPLANTATION; HUMAN; INCIDENCE; INFECTION COMPLICATION; LUNG ASPERGILLOSIS; MEDIASTINITIS; MORTALITY; MUCORMYCOSIS; RESPIRATORY TRACT INFECTION; REVIEW; SERODIAGNOSIS; TOXOPLASMOSIS; VASCULAR DISEASE; VIRUS INFECTION;

EID: 35948954736     PISSN: 0213005X     EISSN: 15781852     Source Type: Journal    
DOI: 10.1157/13111187     Document Type: Article

References (76)

1. Taylor DO, Edwards LB, Boucek MM, Trulock EP, Waltz DA, Keck BM, et al. Registry of the International Society for Heart and Lung transplantation: Twenty-third official adult heart transplantation report 2006. J Heart Lung Tranplant. 2006;25:869-79.
2. Garrido-Cantarero G, Matesanz-Acedos R. Epidemiología de la donación y el trasplante en España. Enferm Infec Microbiol Clin. 2007;25:54-62.
3. Marelli D, Laks H, Kobashigawa JA, Bresson J, Ardehali A, Esmailian F, et al. Seventeen-year experience with 1,083 heart transplants at a single institution. Ann Thorac Surg. 2002;74:1558-66.
4. Montoya JG, Giraldo LF, Efron B, Stinson EB, Gamberg P, Hunt S, et al. Infectious complications among 620 consecutive heart transplant patients at Stanford University Medical Center. Clin Infect Dis. 2001;33:629-40.
5. Grossi P, De Maria R, Caroli A, Zaina MS, Minoli L. Infections in heart transplant recipients: the experience of the Italian heart transplantation program. Italian Study on Infections in Heart Transplantation. J Heart Lung Transplant. 1992;11:847-66.
6. Miller LW, Naftel DC, Bourge RC, Kirklin JK, Brozena SC, Jarcho J, et al. Infection after heart transplantation: A multiinstitutional study. J Heart Lung Transplant. 1994;13:381-92.
7. a ed. Madrid: Elsevier; 2004. p. 445-70.
8. Dummer JS. Risk factors and approaches to infections in transplant patients. En: Mandell GL, Bennett JE, Dolin R, editors. Principles and Practice of Infectious Diseases. 6th ed. Philadelphia: Churchill Livingstone; 2005. p. 3476-86.
9. Muñoz P, Rodríguez C, Bouza E. Heart transplant patients. En: Cohen J, Powderly WG, editors. Infectious diseases. 2nd ed. Mosby: Edinburg; 2004. p. 1115-9.
10. Dummer JS. Infections in solid organ transplant recipients. En: Mandell GL, Bennett JE, Dolin R, editors. Principles and practice of infectious diseases. 6th ed. Philadelphia: Churchill Livingstone; 2005. p. 3501-12.
11. Smart FW, Naftel DC, Costanzo MR, Levine TB, Pelletier GB, Yancy CW Jr, et al. Risk factors for early, cumulative and fatal infections after heart transplantation: A multiinstitutional study. J Heart Lung Transplant. 1996;15:329-41.
12. Muñoz P, Muñoz V, Fogueda M, Blanes M, Cuervas-Mons V, Moreno A, et al. Infectious Complications (IC) after Heart Transplantation (HT). Results of a National Prospective Network in Spain (RESITRA). En: American Society for Microbiology, editor. Abstracts of the 45th Interscience Conference on Antimicrobial Agents And Chemoterapy; 2005. p. 16-19. Washington DC: 2005; (K-1567). p. 357.
13. Kunst H, Paruchuru PK, Madden B. Bacterial endocarditis: A rare complication following orthotopic cardiac transplantation. J Heart Lung Transplant. 2001;20:483-5.
14. Cisneros JM, Muñoz P, Torre-Cisneros J, Gurguí M, Rodríguez-Hernandez MJ, Aguado JM, et al; the Spanish Transplantation Infection Study. Pneumonia after heart transplantation: a multiinstitutional study. Clin Infect Dis. 1998;27:324-31.
15. Stovall SH, Ainley KA, Mason EO Jr, Tucker NC, Frazier EA, Parker JG, et al. Invasive pneumococcal infections in pediatric cardiac transplant patients. Pediatr Infect Dis J. 2001;20:946-50.
16. Stamm AM, Smith SH, Kirklin JK, McGiffin DC. Listeria myocarditis in cardiac transplantation. Rev Infec Dis. 1990;12:820-3.
17. Haddad F, Hunt S, Perlroth M, Valantine H, Doyle R, Montoya J. Pulmonary nocardiosis in a heart transplant patient: case report and review of the literature. J Heart Lung Transplant. 2007;26:93-7.
18. Roberts SA, Franklin JC, Mijch A, Spelman D. Nocardia infection in heart-lung transplant recipients at Alfred Hospital, Melbourne, Australia, 1989-1998. Clin Infect Dis. 2000;31:968-72.
19. Segovia J, Pulpón LA, Crespo MG, Daza R, Rodríguez JC, Rubio A, et al. Rhodococcus equi: First case in a heart transplant recipient. J Heart Lung Transplant. 1994;13:332-5.
20. Prodinger WM, Bonatti H, Allerberger F, Wewalka G, Harrison TG, Aichberger C, et al. Legionella pneumonia in transplant recipients: a cluster of cases of eight years duration. J Hosp Infect. 1994;26:191-202.
21. Horbach I, Fehrenbach FJ. Legionellosis in heart transplant recipients. Infection. 1990;18:361-6.
22. Martín-Santos JM, Alonso-Pulpón L, Pradas G, Cuervas-Mons V, Anguita M, Mulero-Mendoza J, et al. Septic arthritis by Salmonella enteritidis after heart transplantation. J Heart Transplant. 1987;6:177-9
23. Hopkins PM, Winlaw DS, Chhajed PN, Harkness JL, Horton MD, Keogh AM, et al. Mycoplasma hominis infection in heart and lung transplantation. J Heart Lung Transplant. 2002;21:1225-9.
24. Aguado JM, Herrero JA, Gavalda J, Torre-Cisneros J, Blanes M, Rufi G, et al. Clinical presentation and outcome of tuberculosis in kidney, liver, and heart transplant recipients in Spain. Transplantation. 1997;63:1278-86.
25. Freudenberger RS, Simafranca SM. Cutaneous infection with rapidly growing mycobacterial infection following Herat transplant: A case report and review of the literatura. Transplantation Proceed. 2006;38:1526-9.
26. Muñoz P, Bouza E. Infecciones por hongos en el paciente sometido a trasplante de órgano sólido. Enferm Infecc Microbiol Clin. 1997;15 Supl 2:34-50.
27. Grossi P, Farina C, Fiocchi R, Dalla Gasperina D. Prevalence and outcome of invasive fungal infections in 1,963 thoracic organ transplant recipients: a multicenter retrospective study. Italian Study Group of Fungal Infections in Thoracic Organ Transplant Recipients. Transplantation. 2000;15;70:112-6.
28. Wakayama M, Shibuya K, Ando T, Takahashi K, Oharaseki T, Naoe S, et al. Deep-seated mycosis in patients with solid-organ transplantation, a study of autopsied cases in the United States. Kansenshogaku Zasshi. 2000;74:378-86.
29. Loire R, Tabib A, Bastein O. Fatal aspergillosis after cardiac transplantation. About 26 cases. Ann Pathol. 1993;13:157-63.
30. Singh N, Gayowski T, Singh J, Yu VL. Invasive gastrointestinal zygomycosis in a liver transplant recipients: Case report and review of zygomycosis in solid-organ transplant recipients. Clin Infect Dis. 1995;20:617-20.
31. Baraia J, Muñoz P, Bernaldo de Quirós JC, Bouza E. Cutaneous mucormycosis in a heart transplant patient associated with a peripheral catheter. Eur J Clin Microbiol Infect Dis. 1995;14:813-5.
32. Singh N, Chang FY, Gayowski T, Marino IR. Infections due to dematiaceous fungi in organ transplant recipients: case report and review. Clin Infect Dis. 1997;24:369-74.
33. Bodey GP. New fungal pathogens. En: Remington JS, Swartz MN, editors. Current clinical topics in infectious diseases. 17th ed.. Malden: Blackwell Science; 1997. p. 205-35.
34. Rubin RH. Prevention and treatment of cytomegalovirus disease in heart transplant patients. J Heart Lung Transplant. 2000;19:731-5.
35. Singh N. Preemptive therapy versus universal prophylaxis with ganciclovir for cytomegalovirus in solid organ transplant recipients. Clin Infect Dis. 2001;32:742-51.
36. Yamani MH, Avery R, Mawhorter S, Young JB, McNeill A, Cook DJ, et al. Hypogammaglobulinemia after heart transplantation: impact of pre-emptive use of immunoglobulin replacement (CytoGam) on infection and rejection outcomes. Transpl Infect Dis. 2001;3 Suppl 2:40-3.
37. Sarmiento E, Fernández-Yáñez J, Muñoz P, Palomo J, Rodríguez-Molina JJ, Bermejo J, et al. Hypogammaglobulinemia after heart transplantation: use of intravenous immunoglobulin replacement therapy in relapsing CMV disease. Int Immunopharmacol. 2005;5:97-101.
38. Petrakopoulou P, Kubrich M, Pehlivanli S, Meiser B, Reichart B, von Scheidt W, et al. Cytomegalovirus infection in heart transplant recipients is associated with impaired endothelial function. Circulation. 2004;110 (11 Suppl 1):II207-12.
39. Weis M, Kledal TN, Lin KY, Panchal SN, Gao SZ, Valantine HA, et al. Cytomegalovirus infection impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine in transplant arteriosclerosis. Circulation. 2004;109:500-5.
40. Streblow DN, Kreklywich C, Yin Q, De La Melena VT, Corless CL, Smith PA, et al. Cytomegalovirus-mediated upregulation of chemokine expression correlates with the acceleration of chronic rejection in rat heart transplants. J Virol. 2003;77:2182-94.
41. Valantine HA. The role of viruses in cardiac allograft vasculopathy. Am J Transplant. 2004;4:169-77.
42. Potena L, Grigioni F, Ortolani P, Magnani G, Marrozzini C, Falchetti E, et al. Relevance of cytomegalovirus infection and coronary-artery remodeling in the first year after heart transplantation: a prospective three-dimensional intravascular ultrasound study. Transplantation. 2003;75:839-43.
43. Fateh-Moghadam S, Bocksch W, Wessely R, Jager G, Hetzer R, Gawaz M. Cytomegalovirus infection status predicts progression of heart-transplant vasculopathy. Transplantation. 2003;76:1470-4.
44. Van der Bij W, Speich R. Management of cytomegalovirus infection and disease after solid-organ transplantation. Clin Infect Dis. 2001;33 Suppl 1:S32-7.
45. Henderson R, Carlin D, Kohlhase K, Leader S. Multicenter US study of hospital resource utilization associated with cytomegalovirus-related readmission of renal and heart transplant patients. Transpl Infect Dis. 2001;3 Suppl 2:57-9.
46. Egan JJ, Carroll KB, Yonan N, Woodcock A, Crisp A. Valacyclovir prevention of cytomegalovirus reactivation after heart transplantation: a randomized trial. J Heart Lung Transplant. 2002;21:460-6.
47. Razonable RR, Rivero A, Rodríguez A, Wilson J, Daniels J, Jenkins G, et al. Allograft rejection predicts the occurrence of late-onset cytomegalovirus (CMV) disease among CMV-mismatched solid organ transplant patients receiving prophylaxis with oral ganciclovir. J Infect Dis. 2001;184:1461-4.
48. Paya CV. Economic impact of cytomegalovirus in solid organ transplantation. Transpl Infect Dis. 2001;3 Suppl 2:14-9.
49. Paya CV. Prevention of cytomegalovirus disease in recipients of solid-organ transplants. Clin Infect Dis. 2001;32:596-603.
50. Sia IG, Patel R. New strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipients. Clin Microbiol Rev. 2000;13:83-121.
51. Senechal M, Dorent R, du Montcel ST, Fillet AM, Ghossoub JJ, Dubois M, et al. Monitoring of human cytomegalovirus infections in heart transplant recipients by pp65 antigenemia. Clin Transplant. 2003;17:423-7.
52. Anguita J, Rico ML, Palomo J, Muñoz P, Preciado V, Menárguez J. Myocardial Epstein-Barr virus-associated cardiac smooth-muscle neoplasm arising in a cardiac transplant recipient. Transplantation. 1998;66:400-1.
53. Cabezón Ruiz S, Cisneros JM, Lage Galle E, Ordóñez A, Hinojosa RF, Morán Risco JE, et al. Characteristics and repercussion of varicella-zoster virus infection in cardiac transplant. Transplant Proc. 2003;35:2004-5.
54. Gourishankar S, McDermid JC, Jhangri GS, Preiksaitis JK. Herpes zoster infection following solid organ transplantation: incidence, risk factors and outcomes in the current immunosuppressive era. Am J Transplant. 2004;4:108-15.
55. Murtagh B, Wadia Y, Messner G, Allison P, Harati Y, Delgado R. West Nile virus infection after cardiac transplantation. J Heart Lung Transplant. 2005;24:774-6.
56. Bragin-Sánchez D, Chang PP. West Nile virus encephalitis infection in a heart transplant recipient: a case report. J Heart Lung Transplant. 2005;24:621-3.
57. Kumar D, Humar A. Emerging viral infections in transplant recipients. Curr Opin Infect Dis. 2005;18:337-41.
58. Chitlur M, Abella E, Singh TP, Savasan S. Severe neutropenia and thrombocytopenia following cardiac transplantation in a child. Pediatr Transplant. 2005;9:94-6.
59. Nash PJ, Avery RK, Tang WH, Starling RC, Taege AJ, Yamani MH. Encephalitis owing to human herpesvirus-6 after cardiac transplant. Am J Transplant. 2004;4:1200-3.
60. Chua R, Macdonald P. Kaposi's sarcoma occurring in a cardiac transplant patient on tacrolimus. Heart Lung Circ. 2006;15:340-1.
61. Muñoz P, Álvarez P, de Ory F, Pozo F, Rivera M, Bouza E. Incidence and clinical characteristics of Kaposi sarcoma after solid organ transplantation in Spain: importance of seroconversion against HHV-8. Medicine (Baltimore). 2002;81:293-304.
62. Emond JP, Marcelin AG, Dorent R, Milliancourt C, Dupin N, Frances C, et al. Kaposi's sarcoma associated with previous human herpesvirus 8 infection in heart transplant recipients. J Clin Microbiol. 2002;40:2217-9.
63. Muñoz P, Fogeda M, Bouza E, Verde E, Palomo J, Banares R. Prevalence of BK virus replication among recipients of solid organ transplants. Clin Infect Dis. 2005;41:1720-5.
64. Barber CE, Hewlett TJ, Geldenhuys L, Kiberd BA, Acott PD, Hatchette TF. BK virus nephropathy in a heart transplant recipient: case report and review of the literature. Transpl Infect Dis. 2006;8:113-21.
65. Arnold SJ, Kinney MC, McCormick MS, Dummer S, Scott MA. Disseminated toxoplasmosis. Unusual presentations in the immunocompromised host. Arch Pathol Lab Med. 1997;121:869-73.
66. Muñoz P, Arencibia J, Rodríguez C, Rivera M, Palomo J, Yáñez J, et al. Trimethoprim-sulfamethoxazole as toxoplasmosis prophylaxis for heart transplant recipients. Clin Infect Dis. 2003;36:932-3; author reply 933.
67. Guitard J, Kamar N, Mouzin M, Borde JS, Tran-Van T, Durand D, et al. Sulfadiazine-related obstructive urinary tract lithiasis: an unusual cause of acute renal failure after kidney transplantation. Clin Nephrol. 2005;63:405-7.
68. Bocchi EA. Heart transplants for patients with Chagas' heart disease. São Paulo Med J. 1995;113:873-9.
69. Golino A, Duncan JM, Zeluff B, DePriest J, McAllister HA, Radovancevic B, et al. Leishmaniasis in a heart transplant patient. J Heart Lung Transplant. 1992;11:820-3.
70. Chiche L, Lesage A, Duhamel C, Salame E, Malet M, Samba D, et al. Post-transplant malaria: first case of transmission of Plasmodium falciparum from a white multiorgan donor to four recipients. Transplantation. 2003;75:166-8.
71. El Masry HZ, O'Donnell J. Fatal strongyloides hyperinfection in heart transplantation. J Heart Lung Transplant. 2005;24:1980-3.
72. Schaeffer MW, Buell JF, Gupta M, Conway GD, Akhter SA, Wagoner LE. Strongyloides hyperinfection syndrome after heart transplantation: case report and review of the literature. J Heart Lung Transplant. 2004;23:905-11.
73. Walker M, Zunt JR. Parasitic central nervous system infections in immunocompromised hosts. Clin Infect Dis. 2005;40:1005-15.
74. Martín-Rabadán P, Muñoz P, Palomo J, Bouza E. Strongyloidiasis: The Harada-Mori test revisited. Clin Microbiol Infect. 1999;5:374-376.
75. Coll P, Montserrat I, Ballester M, March F, Moya C, Obrador D, et al. Epidemiologic evidence of transmission of donor-related bacterial infection through a transplanted heart. J Heart Lung Transplant. 1997; 16:464-7.
76. Keating MR, Guerrero MA, Daly RC, Walker RC, Davies SF. Transmission of invasive aspergillosis from a subclinically infected donor to three different organ transplant recipients. Chest. 1996;109:1119-24.